Hsueh‐Ju Lu

557 total citations
44 papers, 381 citations indexed

About

Hsueh‐Ju Lu is a scholar working on Otorhinolaryngology, Molecular Biology and Oncology. According to data from OpenAlex, Hsueh‐Ju Lu has authored 44 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Otorhinolaryngology, 15 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Hsueh‐Ju Lu's work include Head and Neck Cancer Studies (17 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (6 papers). Hsueh‐Ju Lu is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (6 papers). Hsueh‐Ju Lu collaborates with scholars based in Taiwan, United States and Canada. Hsueh‐Ju Lu's co-authors include Peter Mu‐Hsin Chang, Muh‐Hwa Yang, Shyh‐Kuan Tai, Ming‐Huang Chen, Pen‐Yuan Chu, Ling-Wei Wang, Chiao‐Wen Lin, Shun‐Fa Yang, Kuo-Wei Chen and Mu‐Kuan Chen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hsueh‐Ju Lu

42 papers receiving 377 citations

Peers

Hsueh‐Ju Lu

ONCOL

PRM

OTORH

Ik Joon Choi South Korea

Hari Prasad Dhakal Norway

Navin Niles Australia

Maria Gebre‐Medhin Sweden

Peiguo Wang China

Neil Majithia United States

Shin Yoshida Japan

Meltem Serin Türkiye

Daniela Paccagnella Italy

Ik Joon Choi South Korea

Hsueh‐Ju Lu

80 ×0.7

94 ×0.8

ONCOL

72 ×0.8

PRM

40 ×0.5

56 ×0.8

OTORH

Citations per year, relative to Hsueh‐Ju Lu Hsueh‐Ju Lu (= 1×) peers Ik Joon Choi

Countries citing papers authored by Hsueh‐Ju Lu

Since Specialization

Citations

This map shows the geographic impact of Hsueh‐Ju Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsueh‐Ju Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsueh‐Ju Lu more than expected).

Fields of papers citing papers by Hsueh‐Ju Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsueh‐Ju Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsueh‐Ju Lu. The network helps show where Hsueh‐Ju Lu may publish in the future.

Co-authorship network of co-authors of Hsueh‐Ju Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsueh‐Ju Lu. A scholar is included among the top collaborators of Hsueh‐Ju Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsueh‐Ju Lu. Hsueh‐Ju Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Hsueh‐Ju, et al.. (2025). Intravoxel incoherent motion (IVIM) MRI-derived masseter muscle characteristics: a new diagnostic marker in head and neck cancer?. BMC Cancer. 25(1). 184–184. 1 indexed citations

Lu, Hsueh‐Ju, Chao‐Yu Shen, Wea‐Lung Lin, et al.. (2024). Radiomic biomarkers for platinum‐refractory head and neck cancer in the era of immunotherapy. Oral Diseases. 30(7). 4220–4230. 2 indexed citations

Lu, Hsueh‐Ju, et al.. (2024). Prognostic impact of caspase-8 mutation in oral cavity squamous cell carcinoma: A real-world cohort study.. Journal of Clinical Oncology. 42(16_suppl). e18029–e18029. 1 indexed citations

Liao, Chun‐Kai, Chia-Jen Liu, Tran‐Der Tan, et al.. (2024). Real World Evidence of Tirabrutinib As a Salvage Treatment in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Multicenter Study. Blood. 144(Supplement 1). 5137–5137.

Lu, Hsueh‐Ju, Chun‐Wen Su, Shih‐Chi Su, et al.. (2024). Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma. Oral Diseases. 31(3). 769–781. 2 indexed citations

Huang, Chi‐Hsien, Shiow‐Ing Wang, Frank S. Fan, Hsueh‐Ju Lu, & James Cheng‐Chung Wei. (2024). Association of PCSK9 inhibitors with mortality: insights from a retrospective cohort analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 10(6). 505–514. 3 indexed citations

Lin, Chiao‐Wen, Wei‐En Yang, Chun‐Wen Su, et al.. (2024). IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through Src-mediated upregulation of EREG in oral cancer. International Journal of Biological Sciences. 20(3). 818–830. 14 indexed citations

Wang, Hung‐Ming, Pei‐Jen Lou, Jin‐Ching Lin, et al.. (2024). Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08). Targeted Oncology. 19(1). 51–58. 1 indexed citations

Lu, Hsueh‐Ju, et al.. (2024). The efficacy and tolerability of bortezomib, thalidomide, and dexamethasone induction therapy with a thalidomide dose step‐up strategy in patients with newly diagnosed multiple myeloma: A prospective observational study. Cancer Reports. 7(5). e2102–e2102. 2 indexed citations

10.

Lin, Chiao‐Wen, et al.. (2023). The impact of FOXP3 polymorphisms on oral cancer progression and clinicopathological characteristics. Journal of Cancer. 14(7). 1195–1201. 3 indexed citations

11.

Lu, Hsueh‐Ju, Chih‐Yu Peng, Hsien‐Chun Tseng, et al.. (2022). Prediction Model of Distant Metastasis in Oral Cavity Squamous Cell Carcinoma With or Without Regional Lymphatic Metastasis. Frontiers in Oncology. 11. 713815–713815. 4 indexed citations

12.

Lu, Hsueh‐Ju, Chih‐Yu Peng, Hsien‐Chun Tseng, et al.. (2022). Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma. Oral Oncology. 131. 105951–105951. 3 indexed citations

13.

Hsieh, Ming‐Hong, Hsueh‐Ju Lu, Chiao‐Wen Lin, et al.. (2021). Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer. Journal of Personalized Medicine. 11(5). 348–348. 13 indexed citations

14.

Lu, Hsueh‐Ju, Chih‐Cheng Hsieh, Yi‐Chen Yeh, et al.. (2019). Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy. Scientific Reports. 9(1). 12913–12913. 8 indexed citations

15.

Lu, Hsueh‐Ju, Kuo-Wei Chen, Ming‐Huang Chen, et al.. (2013). Serum Albumin is an Important Prognostic Factor for Carotid Blowout Syndrome. Japanese Journal of Clinical Oncology. 43(5). 532–539. 6 indexed citations

16.

Liu, Chun‐Yu, Hsueh‐Ju Lu, Man‐Hsin Hung, et al.. (2013). Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era. Annals of Hematology. 92(11). 1513–1520. 15 indexed citations

17.

Chang, Peter Mu‐Hsin, Yi‐Chen Yeh, Tzu-Chi Chen, et al.. (2013). High Expression of CHRNA1 is Associated with Reduced Survival in Early Stage Lung Adenocarcinoma after Complete Resection. Annals of Surgical Oncology. 20(11). 3648–3654. 11 indexed citations

18.

Chen, Kuo-Wei, Chia‐Jen Liu, Hsueh‐Ju Lu, et al.. (2012). Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study. BMC Research Notes. 5(1). 70–70. 9 indexed citations

19.

Lu, Hsueh‐Ju, Kuo-Wei Chen, Cheng‐Hwai Tzeng, et al.. (2012). Evaluation of Prognosis for Carcinoma of Unknown Origin in Elderly Patients. Oncology. 83(1). 24–30. 7 indexed citations

20.

Tai, Chun‐Hwei, Ruey‐Meei Wu, Chin‐Hsien Lin, et al.. (2010). Deep brain stimulation therapy for Parkinson’s disease using frameless stereotaxy: comparison with frame‐based surgery. European Journal of Neurology. 17(11). 1377–1385. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact